Wednesday, May 10, 2017 12:48:04 AM
There will be lots of resistance with upward stock movement bc we have bagholders at seemingly every range for both commons and warrants. Hope management gets it all cleared, or we might be range bound with all the uncertainty. Every single catalyst so far has been met with an initial spike and quick downward movement.
My original thesis was based on a quick ROI from use of the 505(b)(2) pathway for combo drug in great need. Why the heck would a company do a 505(b)(2) drug only to buy a preclinical cancer drug that's five years away from being five years away. To a great degree, I would hope this is still posturing from management to add another asset to their pipeline which they were able to buy low and sell high.
In any case we should get the NDA soon, and I will be eager to see the markets response.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM